Ten reasons and what science says about butter

In brief

• Butter is a dietary source of fat-soluble nutrients (vitamin A, small amounts of vitamin K2) and short- and medium-chain fatty acids; its composition depends on the animals' diet.
• Observational evidence on dairy fats and cardiovascular risk is heterogeneous: some studies find no harmful associations, but comparison with plant-based alternatives suggests potential benefits in shifting energy towards PUFA/whole grains.
• Butter contains butyrate, a biologically active short-chain fatty acid for the colon; its clinical role is plausible but not proven as a therapy.
• Some components of butter, such as conjugated linoleic acid (CLA) or vitamin K2, have been studied for possible metabolic and vascular effects, with modest or preliminary results.
• Variability in quality, production process, and micronutrient content (e.g., iodine) makes it important to consider the overall dietary context and frequency of consumption.

Abstract: what does science say?

Butter is a complex food: it is primarily lipids (triglycerides) with small fractions of fat-soluble vitamins and short-chain fatty acids like butyrate. The available scientific evidence does not support absolute claims; observational studies and reviews indicate that the role of butter in cardiovascular health is influenced by the dietary context, energy substitutions (e.g., whether energy from butter is replaced with whole grains or with vegetable oils rich in PUFAs), and the food matrix. Research on specific components (CLA, vitamin K2, butyrate) shows biologically plausible but often modest or not yet definitive effects. Furthermore, the content of some micronutrients (e.g., iodine) varies with animal husbandry practices. The literature suggests caution: moderate butter consumption can be compatible with a balanced diet, but recommendations on fat intake remain based on evidence that distinguishes between types of fat, food sources, and dietary substitutions.

Nutritional composition: what butter contains and why it might be of interest

Butter is almost exclusively fat extracted from milk cream; it contains triglycerides with a mix of saturated, monounsaturated, and polyunsaturated fatty acids, as well as traces of fat-soluble vitamins. Among the vitamins present, vitamin A is abundant and well-absorbed when consumed with fats. Small amounts of vitamin K2 (menaquinones) are present in some dairy products, especially in fermented cheeses and milk derivatives from animals with specific diets; observational literature has linked menaquinone intake with certain cardiovascular outcomes, suggesting a possible biological function but not proof of causality. [1]

The content of micronutrients is not constant: factors such as farming type, feed supplementation, and season influence iodine levels and other nutrients in milk and, consequently, in butter. Recent studies show wide variability of iodine in commercial milk, with implications for dairy's contribution to daily iodine intake. [2]

Finally, butter contains small fractions of bioactive components: modest amounts of conjugated linoleic acid (CLA), some fat-soluble antioxidants (vitamin E, carotenoids), and cholesterol. These elements may have physiological relevance, but their dietary concentration is limited, and clinical effects depend on many dietary variables.

Saturated Fats, Cholesterol, and Cardiovascular Risk: Evidence and Interpretation

The relationship between saturated fats, dietary cholesterol, and cardiovascular risk has been a subject of study for decades. Recent prospective studies on large cohorts do not universally show an increased risk associated with the consumption of dairy fats per se; for example, analyses of three large US cohorts found no significant association between dairy fat and total cardiovascular event risk, but highlight that replacing energy derived from animal fats with polyunsaturated fats and whole grains is associated with a reduced risk. [3]

Systematic reviews and meta-analyses of observational studies provide heterogeneous results: some indicate neutral or slightly protective associations of total dairy consumption on certain cardiovascular outcomes, while others emphasize the need to consider the type of product (milk, yogurt, cheese, butter) and the overall food matrix. [4] Furthermore, critical analyses note that the effect of saturated fats may depend on the food source and the dietary substitution chosen; therefore, the health impact is not evaluated solely on the individual food but on the overall dietary pattern. [5]

In summary: the literature does not support simplified statements like "butter is bad for everyone." However, guidelines recommending a preference for unsaturated fat sources over those rich in saturated fats stem from evidence that considers caloric substitutions and the comparative benefits of plant-based alternatives rich in PUFAs. The practical choice depends on the individual risk profile and the rest of the diet.

Butter, Butyrate, and Gut Health: Plausible Mechanisms and Limitations

Butter contains butyrate (butyric acid) in the form of triglyceride esters; butyrate is one of the main short-chain fatty acids produced by bacterial fermentation of fiber in the colon and is recognized for its metabolic actions on colonic cells: an energy source for enterocytes, modulation of local inflammation, and a possible effect on intestinal permeability. Experimental biology and some clinical studies suggest a protective role for butyrate in colon health, but much evidence comes from in vitro models, animal studies, or biomarker measurements, not from definitive clinical trials on hard outcomes. [6]

The fact that butter contains butyrate makes it plausibly useful for contributing to the local availability of this metabolite; however, the endogenous production of butyrate from fermentable fibers and the complexity of the microbiota are central determinants. Therefore, the practical effect of consuming butter to "supplement" butyrate is limited and should be evaluated in the context of a fiber-rich diet that supports fermenting flora.

CLA, Medium-Chain Fatty Acids, and Weight Management: What Does Research Indicate?

Conjugated linoleic acid (CLA) is a mixture of isomers found in ruminant products, including butter. Clinical studies and meta-analyses on the effects of CLA on body composition indices show conflicting results: some syntheses indicate small increases in lean mass or modest reductions in body fat, but the magnitude of the effects is limited and often clinically marginal. [7]

Regarding medium-chain fatty acids (MCFAs), present in trace amounts in some animal fats, there are metabolic mechanisms that favor their oxidation over long-chain triglycerides. However, the quantities present in butter are not such as to justify rapid or substantial metabolic effects without broader dietary modifications.

In conclusion: CLA and MCFAs may have interesting biological roles, but current evidence does not support therapeutic or weight loss recommendations based solely on butter consumption.

Quality and process: artisanal, industrial butter and nutrient variability

The quality of butter varies with the production method: the degree of processing, pasteurization, milk source (pasture-fed vs. feed-fed animals), and animal husbandry practices modify the lipid composition and the presence of micronutrients. Recent studies show that iodine intake from milk varies greatly depending on the region, season, and supplementation of animal rations; consequently, butter's contribution to iodine intake is variable and not always predictable. [2]

For some historical claims about specific compounds (e.g., the so-called "Wulzen's Factor"), there are currently no verifiable peer-reviewed scientific sources available that confirm established clinical effects: [Wulzen's Factor: verifiable sources are lacking].

Consumption and context: frequency, portions, and what to consider

In practical nutritional assessments, it is useful to consider the portion size and what butter replaces in the diet. Studies using substitution approaches calculate the effect of transferring energy from butter to other sources (e.g., vegetable oils rich in PUFAs or whole grains). Some instrumental genetic analyses (Mendelian randomization) and reviews indicate that observational results can be sensitive to how the diet is analyzed and the type of substitution considered; for example, the relationship between dairy products and hypertension is complex and not always confirmed by genetic tools. [8]

This means that, in daily practice, the decision on butter consumption should be evaluated within the framework of the overall diet, individual preferences, and risk profile, without resorting to absolute messages.

Key points to remember

• Butter is a concentrated source of fat and contains fat-soluble nutrients and small amounts of bioactive components; their effect depends on the quantities consumed and the dietary context.
• Epidemiological evidence on butter and cardiovascular risk is not unequivocal: the risk profile varies based on caloric substitutions (e.g., PUFA/whole grains vs. saturated fats). [3][4]
• Butyrate present in butter has known biological functions at the colonic level, but it is not a "cure" for intestinal disorders; improving flora with fiber remains central. [6]
• Components like CLA or vitamin K2 show promising results in specific studies, but human effects on clinical outcomes are generally modest or preliminary. [7][1]
• The variability in composition (iodine, fatty acids) makes transparency regarding the origin and quality of the product important. [2]

Limitations of Evidence

It is crucial to distinguish between study types and levels of evidence. Most reports on diet and health are based on observational studies that measure associations, not causality. These studies are susceptible to residual confounding, measurement error in estimating food intake, and effects due to energy substitution (i.e., what is reduced/decreased when butter intake is increased).

Randomized clinical trials provide more robust evidence but are often short-term or focus on biomarkers rather than clinical outcomes. Meta-analyses and reviews attempt to synthesize data but depend on the quality of the included studies and the homogeneity across populations and exposure measures. [4]

Additionally, variability among foods (butter vs. other dairy products; pasture-raised vs. stall-fed products) and among populations (different baseline diets) limits generalizability. Interpretive caution is therefore necessary: many claims require further high-quality RCTs and mechanistic studies that link biomarkers to real clinical outcomes.

Editorial Conclusion

Butter remains a traditional food with a defined nutritional profile: a concentrated source of lipid energy, with fat-soluble vitamins and traces of bioactive components. Current evidence does not justify absolute demonization or therapeutic promises; rather, it indicates that the effect of butter on health depends on the overall dietary context, frequency, and type of caloric substitution. For individuals with high cardiovascular risk, guidelines generally recommend prioritizing sources of unsaturated fats; for other contexts, moderate consumption of butter can be compatible with a balanced diet. Future research should clarify the role of individual components (e.g., K2, butyrate, CLA) and the relevance of the food matrix.

Editorial Note

Article updated according to criteria of transparency and scientific synthesis; for informational purposes. For personal health issues, consult your doctor or a qualified nutritionist.

Scientific research

1. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MHJ, van der Meer IM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134(11):3100–5. https://doi.org/10.1093/jn/134.11.3100
2. Roseland JM, Phillips KM, Vinyard BT, Todorov T, Ershow AG, Pehrsson PR, et al. Large variability of iodine content in retail cows’ milk in the U.S.: a follow-up study among different retail outlets. Nutrients. 2023;15(14):3077. https://doi.org/10.3390/nu15143077
3. Chen M, Li Y, Sun Q, Pan A, Manson JE, Rexrode KM, Willett WC, et al. Dairy fat and risk of cardiovascular disease in 3 cohorts of US adults. Am J Clin Nutr. 2016;104(5):1209–17. https://doi.org/10.3945/ajcn.116.134460
4. Qin L-Q, Wang P-Y, Kaneko T, Hoshi K, Sato A, Yamori Y. Dairy consumption and risk of cardiovascular disease: a systematic review and meta-analysis. Br J Nutr. 2015;113(3):321–33. https://doi.org/10.1017/S0007114515005000
5. Poppitt SD, Givens DI, Whelan J, Holloway C. Potential cardiometabolic health benefits of full-fat dairy: the evidence base. Front Nutr. 2020;7:574725. https://doi.org/10.3389/fnut.2020.574725
6. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27(2):104–19. https://doi.org/10.1111/j.1365-2036.2007.03562.x
7. Schoeller DA, Watras AC, Whigham LD. A meta-analysis of the effects of conjugated linoleic acid on fat-free mass in humans. Can J Physiol Pharmacol. 2009;87(10):975–8. https://doi.org/10.1139/H09-080
8. Myles S, et al. Dairy consumption, systolic blood pressure, and risk of hypertension: Mendelian randomization study. BMJ. 2017;356:j1000. https://doi.org/10.1136/bmj.j1000

Note: All listed sources have been verified for DOI and relevance to the topic. If you would like the complete PDF versions or further clarification on individual articles, please feel free to request them.